Published in
Taylor and Francis Group, Leukemia & Lymphoma, 11(53), p. 2136-2142
DOI: 10.3109/10428194.2012.681655
Links
- ORCID
- Taylor and Francis Group
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia
Journal article published in 2012 by
John C. Byrd,
Thomas J. Kipps,
Ian W. Flinn 
,
Maureen Cooper,
Olatoyosi Odenike,
Jennifer Bendiske,
John Rediske,
Sanela Bilic,
Jyotirmoy Dey,
Johan Baeck,
Susan O’Brien
,
Maureen Cooper,
Olatoyosi Odenike,
Jennifer Bendiske,
John Rediske,
Sanela Bilic,
Jyotirmoy Dey,
Johan Baeck,
Susan O’Brien
This paper is available in a repository.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 